跳至主要内容
临床试验/NCT01401413
NCT01401413已完成4 期

A Prospective Randomized, Placebo-Controlled Double-Blind Study to Determine the Efficacy of Ramelteon in REM Sleep Behavior Disorder

Sleep Medicine Centers of WNY1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2008年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Change in polysomnographic scores

研究概览

简要总结

The purpose of this study is to determine whether the use of the drug ramelteon decreases the symptoms of REM Sleep Behavior Disorder.

详细描述

This is a randomized double blind placebo controlled study to determine whether the use of ramelteon decreases symptoms of RBD. Outcome measures are determined by change in RBD polysomnographic score and assessment scores on the RBD symptom questionnaire and sleep diary.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meets criteria for RBD as determined by screening PSG's
  • steady bed partner for completion of RBD questionnaire

排除标准

  • Hepatic impairment
  • RBD associated with narcolepsy
  • use of fluvoxamine, rifampin, fluconazole or ketoconazole
  • current alcohol or drug abuse

研究组 & 干预措施

1

Placebo Comparator

placebo control nightly

干预措施: placebo (Drug)

2

Active Comparator

8 mg ramelteon nightly

干预措施: ramelteon (Drug)

结局指标

主要结局

Change in polysomnographic scores

时间窗: 30 days

次要结局

  • change in RBD symptom questionnaire and sleep diary(30 days)

研究者

发起方
Sleep Medicine Centers of WNY
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Study to Determine Whether Ramelteon Helps People... | 临床试验